Literature DB >> 15735979

Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family.

Carla Oliveira1, Herculano Moreira, Raquel Seruca, Manuel Cardoso de Oliveira, Fátima Carneiro.   

Abstract

Mutations in E-cadherin gene are the underlying genetic defect in approximately one-third of the hereditary diffuse gastric cancer (HDGC) families described to date. Positive family history of diffuse gastric cancer and early age of onset of gastric tumours are the clinical criteria currently used to qualify for HDGC. In the present study, we describe a Portuguese family with HDGC that was selected for CDH1 mutation screening after histological observation of the gastrectomy specimen of one member, who died at the age of 23 years from widely invasive diffuse gastric carcinoma. The detection in the surgical specimen of tiny foci of intramucosal diffuse carcinoma as well as in situ carcinoma lesions and pagetoid spread of signet ring cells raised the hypothesis of HDGC, which was confirmed by pedigree analysis of the family and detection of CDH1 germline mutation. We conclude that there are morphological hints that may help in the identification of HDGC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15735979     DOI: 10.1007/s00428-004-1156-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

Review 1.  Familial gastric cancer: overview and guidelines for management.

Authors:  C Caldas; F Carneiro; H T Lynch; J Yokota; G L Wiesner; S M Powell; F R Lewis; D G Huntsman; P D Pharoah; J A Jankowski; P MacLeod; H Vogelsang; G Keller; K G Park; F M Richards; E R Maher; S A Gayther; C Oliveira; N Grehan; D Wight; R Seruca; F Roviello; B A Ponder; C E Jackson
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

2.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

Authors:  D G Huntsman; F Carneiro; F R Lewis; P M MacLeod; A Hayashi; K G Monaghan; R Maung; R Seruca; C E Jackson; C Caldas
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

3.  Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands.

Authors:  Gianpaolo Suriano; Carla Oliveira; Paulo Ferreira; José C Machado; Maria C Bordin; Olivier De Wever; Erik A Bruyneel; Nicole Moguilevsky; Nicola Grehan; Timothy R Porter; Frances M Richards; Ralph H Hruban; Franco Roviello; David Huntsman; Marc Mareel; Fátima Carneiro; Carlos Caldas; Raquel Seruca
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

4.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

5.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

6.  Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.

Authors:  Fátima Carneiro; David G Huntsman; Thomas C Smyrk; David A Owen; Raquel Seruca; Paul Pharoah; Carlos Caldas; Manuel Sobrinho-Simões
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

7.  Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.

Authors:  R C Fitzgerald; C Caldas
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

8.  Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone.

Authors:  A Charlton; V Blair; D Shaw; S Parry; P Guilford; I G Martin
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

9.  Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.

Authors:  Beatrix Vécsey-Semjén; Karl-Friedrich Becker; Alexandra Sinski; Elizabeth Blennow; Ilja Vietor; Kurt Zatloukal; Hartmut Beug; Ernst Wagner; Lukas A Huber
Journal:  Oncogene       Date:  2002-07-11       Impact factor: 9.867

10.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.

Authors:  A R Brooks-Wilson; P Kaurah; G Suriano; S Leach; J Senz; N Grehan; Y S N Butterfield; J Jeyes; J Schinas; J Bacani; M Kelsey; P Ferreira; B MacGillivray; P MacLeod; M Micek; J Ford; W Foulkes; K Australie; C Greenberg; M LaPointe; C Gilpin; S Nikkel; D Gilchrist; R Hughes; C E Jackson; K G Monaghan; M J Oliveira; R Seruca; S Gallinger; C Caldas; D Huntsman
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

View more
  10 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  CDH1/E-cadherin germline mutations in early-onset gastric cancer.

Authors:  J T Bacani; M Soares; R Zwingerman; N di Nicola; J Senz; R Riddell; D G Huntsman; S Gallinger
Journal:  J Med Genet       Date:  2006-06-26       Impact factor: 6.318

3.  A model to infer the pathogenic significance of CDH1 germline missense variants.

Authors:  Gianpaolo Suriano; Susana Seixas; Jorge Rocha; Raquel Seruca
Journal:  J Mol Med (Berl)       Date:  2006-08-16       Impact factor: 4.599

4.  A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?

Authors:  Domenico Ciliberto; Nicoletta Staropoli; Francesca Caglioti; Simona Gualtieri; Lucia Fiorillo; Silvia Chiellino; Antonina Maria De Angelis; Francesco Mendicino; Cirino Botta; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Journal:  Cancer Biol Ther       Date:  2015-06-10       Impact factor: 4.742

5.  The sex ratio and age of onset features of gastric cancer patients in hereditary diffuse gastric cancer families.

Authors:  Junxiu Yu; Zhenfang Li
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

6.  Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC).

Authors:  Carla Oliveira; Raquel Seruca; Nicoline Hoogerbrugge; Marjolijn Ligtenberg; Fátima Carneiro
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

7.  Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.

Authors:  Michael D Black; Raynette Kaneshiro; Jennifer I Lai; David M Shimizu
Journal:  Hawaii J Med Public Health       Date:  2014-07

8.  Gastric cancer: Classification, histology and application of molecular pathology.

Authors:  Bing Hu; Nassim El Hajj; Scott Sittler; Nancy Lammert; Robert Barnes; Aurelia Meloni-Ehrig
Journal:  J Gastrointest Oncol       Date:  2012-09

9.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

10.  E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.

Authors:  Joana Simões-Correia; Joana Figueiredo; Rui Lopes; François Stricher; Carla Oliveira; Luis Serrano; Raquel Seruca
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.